Last reviewed · How we verify

NCT06140706

Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI

Not yet recruiting NA Last updated 10 April 2025
What this trial tests

NA trial testing transcutaneous Spinal Cord Stimulation (tSCS) in Tetraplegia in 10 participants. Not yet recruiting.

Timeline
1 September 2025
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorVA Palo Alto Health Care System
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment10
Start date1 September 2025
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Palo Alto Health Care System

Who can join

Adults 18 to 75, any sex, with Tetraplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study will focus on the feasibility of and effectiveness to a home-based program for persons with chronic SCI focused on upper limb training augmented with a transcutaneous neurostimulator supported via a video telehealth platform.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tetraplegia

Currently open trials in the same condition.

Other VA Palo Alto Health Care System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing